HealthDaily digest, November 4, 2026
AI in Healthcare: Promise vs. Reality
This digest examines the gap between AI's ambitious claims and actual medical breakthroughs. While pharmaceutical leaders remain skeptical about near-term disease cures, researchers are making practical progress in using AI to prevent specific patient complications.
Pharma Industry Dismisses Claims AI Will Cure Most Diseases Soon
Pharmaceutical leaders doubt assertions that AI will cure most diseases within a decade, pointing out that the US FDA has not yet approved any AI-designed biotech drugs. Biology continues to present major obstacles to realizing these ambitious promises in drug development.
Why it matters: This highlights the gap between AI hype and biomedical reality, affecting patient expectations and investment decisions in AI-driven drug discovery.
Sources: via Techmeme
$4 Million NIH Grant Funds AI System to Predict Surgical Kidney Injury
Mount Sinai researchers received a $4 million grant from the National Institutes of Health to develop AI models that predict acute kidney injury risk in surgery patients. The system aims to identify high-risk individuals early, enabling preventive care and reducing serious complications and hospital stays.
Why it matters: Better prediction of kidney injury could help doctors prevent serious complications and reduce hospital stays for patients undergoing surgery.
Sources: MedCity News